You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-TGF beta 1 antibody [TB21] (ab27969)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-TGF beta 1 antibody [TB21]
See all TGF beta 1 products (17) ...

Description

Mouse monoclonal [TB21] to TGF beta 1

Specificity

This antibody recognises natural and recombinant TGF beta 1. It reacts with both dimeric and monomeric natural forms under reducing and non reducing conditions.

Tested applications

IHC-Fr, IHC-P, ELISA, ICC/IF, Neutralising, WBmore details

Cross reactivity

Reacts with

Rat, Sheep, Human

Immunogen

Human TGF Beta 1 from human platelets.

Positive control

Human breast carcinoma.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.09% Sodium Azide.
Constituents: PBS.

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Primary antibody notes

This clone (TB21) demonstrates neutralising activity against TGF beta 1 in cell proliferation assays. Removal of sodium azide is recommended prior to use in functional assays.

Clonality

Monoclonal

Clone number

TB21

Myeloma

Sp2/0-Ag14

Isotype

IgG1

Light chain type

kappa

  • Immunohistochemistry (Frozen sections) - TGF beta 1 antibody [TB21] (ab27969)Immunohistochemistry (Frozen sections) - TGF beta 1 antibody [TB21] (ab27969) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - TGF beta 1 antibody [TB21] (ab27969)Immunocytochemistry/ Immunofluorescence - TGF beta 1 antibody [TB21] (ab27969) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab27969 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts.

Tissue specificity

Highly expressed in bone. Abundantly expressed in articular cartilage and chondrocytes and is increased in osteoarthritis (OA). Co-localizes with ASPN in chondrocytes within OA lesions of articular cartilage.

Involvement in disease

Defects in TGFB1 are the cause of Camurati-Engelmann disease (CE) [MIM:131300]; also known as progressive diaphyseal dysplasia 1 (DPD1). CE is an autosomal dominant disorder characterized by hyperostosis and sclerosis of the diaphyses of long bones. The disease typically presents in early childhood with pain, muscular weakness and waddling gait, and in some cases other features such as exophthalmos, facial paralysis, hearing difficulties and loss of vision.

Sequence similarities

Belongs to the TGF-beta family.

Post-translational
modifications

Glycosylated.
The precursor is cleaved into mature TGF-beta-1 and LAP, which remains non-covalently linked to mature TGF-beta-1 rendering it inactive.

Cellular localization

Secreted > extracellular space > extracellular matrix.

Target information above from: UniProt accessionP01137 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Camurati Engelmann disease antibody
  • CED antibody
  • Diaphyseal dysplasia 1 progressive antibody
  • DPD1 antibody
  • LAP antibody
  • Latency-associated peptide antibody
  • TGF beta 1 antibody
  • TGF beta antibody
  • TGF beta 1 protein antibody
  • TGF-beta-1 antibody
  • TGF-beta-5 antibody
  • TGF-beta1 antibody
  • TGFB 1 antibody
  • TGFB antibody
  • Tgfb-1 antibody
  • TGFB1 antibody
  • TGFB1_HUMAN antibody
  • TGFbeta antibody
  • TGFbeta1 antibody
  • Transforming Growth Factor b1 antibody
  • Transforming Growth Factor beta 1 antibody
  • Transforming growth factor beta 1a antibody
see all

Anti-TGF beta 1 antibody [TB21] images:

  Immunohistochemistry (Frozen sections) - TGF beta 1 antibody [TB21] (ab27969)

Immunohistochemistry (Frozen sections) - TGF beta 1 antibody [TB21] (ab27969)

ab27969 staining TGF beta 1 in rat kidney tissue sections by Immunohistochemistry (frozen sections). Tissue was fixed with acetone and then blocked with 2% BSA for 2 hours at 25°C followed by incubation with the primary antibody, at a 1/200 dilution, for 9 hours at 4°C. The secondary antibody used was a goat anti-mouse IgG conjugated to Alexa Fluor® 594 (red) used at a 1/500 dilution.

Image courtesy of an anonymous Abreview.

See Abreview

  Immunocytochemistry/ Immunofluorescence - TGF beta 1 antibody [TB21] (ab27969)

Immunocytochemistry/ Immunofluorescence - TGF beta 1 antibody [TB21] (ab27969)

ab 27969 staining TGF beta 1 in human 293ft cells by Immunocytochemistry/ Immunofluorescence.

The 293 FT cells were cultured for 3 days then fixed with 3.7% formaldehyde for 10 minutes and blocked with 5% BSA in PBS for 1 hour at +4°C. The cells were incubated with the primary antibody at 1/200 dilution overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 555 Goat anti-Rabbit IgG used at a dilution of 1/200.

Image courtesy of an anonymous Abreview.

References for Anti-TGF beta 1 antibody [TB21] (ab27969)

This product has been referenced in:

  • Wang Let al. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells. Clin Cancer Res 16:164-73 (2010). ICC/IF, IHC-P; Human.Read more (PubMed: 20028741) »
  • Minoo Pet al. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 37:707-18 (2010). IHC-P; Human.Read more (PubMed: 20664940) »

See all 7 publications for this product

Publishing research using ab27969? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"